Skip links
Companies
› United States › PHATHOM PHARMACEUTICALS, INC.
Company registry profile
PHATHOM PHARMACEUTICALS, INC. logo

PHATHOM PHARMACEUTICALS, INC.

Active

From the registry

Registration details

Registration No.
6701876
Incorporation Date
2018-09-01
Company Type
Not disclosed
Address
United States
Website
www.phathompharma.com/
Status
Active
Country
United States
Source: Delaware Division of CorporationsRegistry coverage
Registry summary

Company overview

PHATHOM PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 6701876, and its current status with Delaware Division of Corporations is active. The company was incorporated on 1 September 2018 and lists its registered address as United States. 3 shareholders are on record for PHATHOM PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.

Data Provenance
This record is sourced directly from official government registries, including Delaware Division of Corporations.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

3

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Frazier Life Sciences Management, L.P. 15.7% Delaware Division of Corporations
Vanguard Group Inc 5.9% Delaware Division of Corporations

Registry notes and limitations

Three shareholders are currently on record for PHATHOM PHARMACEUTICALS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Frazier Life Sciences Management, L.P. , holding 15.7% — the largest recorded stake — followed by Vanguard Group Inc at 5.9%; the remaining 1 shareholder shown holds smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

5

TJ
Terrie J. Curran ACTIVE

Residence
🇺🇸 United States
Occupation
President, Ceo & Director

TH
Tom Harris ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Development Sciences Officer

MH
Molly Henderson Cpa, Mba ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Financial & Business Officer

PC
Paul Cocja ACTIVE

Residence
🇺🇸 United States
Occupation
Chief People Officer

EL
Eckhard Leifke M.d., Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Medical Officer

Registry notes and limitations

The President, Ceo & Director of PHATHOM PHARMACEUTICALS, INC. currently on record is Terrie J. Curran; five officers are currently on record for PHATHOM PHARMACEUTICALS, INC., filed with Delaware Division of Corporations.

The register reports 19 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at PHATHOM PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Registry questions

Frequently asked questions

Who owns PHATHOM PHARMACEUTICALS, INC.?

Three shareholders are currently on record for PHATHOM PHARMACEUTICALS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Frazier Life Sciences Management, L.P. , holding 15.7% — the largest recorded stake — followed by Vanguard Group Inc at 5.9%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is PHATHOM PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for PHATHOM PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does PHATHOM PHARMACEUTICALS, INC. have on record?

3 shareholders are shown on record for PHATHOM PHARMACEUTICALS, INC..

What is PHATHOM PHARMACEUTICALS, INC.'s company registration number?

PHATHOM PHARMACEUTICALS, INC.'s registration number is 6701876, filed with Delaware Division of Corporations in United States. Its current status on the register is active.

Is PHATHOM PHARMACEUTICALS, INC. still an active company?

PHATHOM PHARMACEUTICALS, INC.'s status on Delaware Division of Corporations is listed as active.

When was PHATHOM PHARMACEUTICALS, INC. incorporated?

PHATHOM PHARMACEUTICALS, INC. was incorporated on 1 September 2018, according to Delaware Division of Corporations.

What is PHATHOM PHARMACEUTICALS, INC.'s registered address?

The registered address on file for PHATHOM PHARMACEUTICALS, INC. is United States.

Who are the officers/directors of PHATHOM PHARMACEUTICALS, INC.?

The President, Ceo & Director of PHATHOM PHARMACEUTICALS, INC. currently on record is Terrie J. Curran; five officers are currently on record for PHATHOM PHARMACEUTICALS, INC., filed with Delaware Division of Corporations. Management authority at PHATHOM PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

This website uses cookies to improve your web experience.